Trump promises more tariff letters and warns BRICS of what’s coming President Trump took to Truth Social again on Tuesday and amped up his trade threats, promising to unveil tariffs on at least ...

Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced non ...